Oral florid papillomatosis: Topical treatment with 5% imiquimod in orabase.
Pedro Ruiz-HuertasAlicia Borrego-LuquePilar Toledano-ValeroCarolina ManzottiÁngel Rollón-MayordomoPublished in: Clinical and experimental dental research (2022)
After reviewing the literature and according to our knowledge, this is the first published case of oral florid papillomatosis treated topically with imiquimod 5% successfully. Topical treatment with imiquimod 5% in orabase may be a valid alternative for patients with recurrent OFP located in the anterior area of the oral cavity who refuse surgical treatment, although we must closely monitor the patient for the possibility of recurrence or malignant degeneration.